Clinical Trial Results: Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation [NA]

View source ↗

Summary

Clinical trial results for the WATCHMAN device in patients unsuitable for oral anticoagulation have been posted; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Watchman

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Stroke | NA | Status: TERMINATED | Results posted: 2026-08-25